The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 2 rounds in the feed, most often in Biotech.
At MintPharma Capital, we are passionate about investing in biotech innovation.
Venture capitalmintpharmacapital.comRounds from 2026-09-30 to 2026-10-08
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Vinci Pharmaceuticals Vinci Pharmaceuticals is disrupting retinal disease treatment with EPIPLANT™, a proprietary needle free drug delivery platform. | Series A Verified against 4 of 13 sources | $8M | 2026-10-08 | [ PART ] |
Astrocyte Pharmaceuticals A clinical-stage biotechnology company developing first-in-class cerebroprotective therapies for concussion, traumatic brain injury (TBI) and stroke | Series B Verified against 4 of 9 sources | $9.5M | 2026-09-30 |
| [ PART ] |